Evidence map›Paper›PMID 32021125›Full record

ArticlePatient preference and adherence2020

Does Antiretroviral Therapy Packaging Matter? Perceptions and Preferences of Antiretroviral Therapy Packaging for People Living with HIV in Northern Tanzania.

Charles Muiruri, Shelley A Jazowski, Seleman K Semvua, Francis P Karia, Brandon A Knettel, Leah L Zullig, Habib O Ramadhani, Blandina T Mmbaga, John A Bartlett, Hayden B Bosworth

Abstract read
In one paragraph

Article in Patient preference and adherence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charles MuiruriDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0003-0213-0362
Shelley A JazowskiDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Seleman K SemvuaDepartment of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.ORCID 0000-0002-7660-9192
Francis P KariaDepartment of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.ORCID 0000-0003-0943-7666
Brandon A KnettelDuke Global Health Institute, Duke University, Durham, NC, USA.ORCID 0000-0003-2986-1579
Leah L ZulligDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Habib O RamadhaniDepartment of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.ORCID 0000-0002-0738-7362
Blandina T MmbagaDuke Global Health Institute, Duke University, Durham, NC, USA.ORCID 0000-0002-5550-1916
John A BartlettDuke Global Health Institute, Duke University, Durham, NC, USA.
Hayden B BosworthDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0001-6188-9825

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
Assess and Adapt to the Impact of COVID-19 on CVD Self Management and Prevention Care in Adults Living with HIV (AAIM-High)U01HL142099 · NHLBI · UNIVERSITY OF WASHINGTON · PI BOSWORTH, HAYDEN B, LONGENECKER, CHRIS TODD · 2018 to 2021
$4.8M
Sociobehavioral Sciences Research to Improve Care for HIV Infection in TanzaniaD43TW009595 · FIC · KILIMANJARO CHRISTIAN MEDICAL CENTRE · PI Blandina Theophil Mmbaga · 2013 to 2026
$4.2M
Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIVR01MD013493 · NIMHD · DUKE UNIVERSITY · PI BLOOMFIELD, GERALD SAMUEL · 2018 to 2022
$3.3M
FIC NIH HHS D43 TW009595HSRD VA IK6 HX003161NHLBI NIH HHS U01 HL142099NIAID NIH HHS P30 AI064518NIMHD NIH HHS R01 MD013493
6 · The paper itself

Abstract

introductionDespite improvements in treatment (eg, reduction in pill intake), antiretroviral therapy (ART) is dispensed in socially inefficient and uneconomical packaging. To make pills less conspicuous and decrease the risk of being stigmatized, people living with HIV (PLWH) often engage in self-repackaging - the practice of transferring ART from original packaging to alternative containers. This behavior has been associated with ART nonadherence and failure to achieve viral load suppression. While much of the literature on ART packaging has centered around medication adherence, patients stated preferences for ART packaging and packaging attributes that influence the observed ART nonadherence are understudied.

methodsWe conducted a qualitative study to elucidate perceptions of ART packaging among PLWH at two large referral hospitals in Northern Tanzania. Interviews were conducted until thematic saturation was reached. Interviews were audio-recorded, transcribed and coded.

resultsOf the 16 participants whose data were used in the final analysis, a majority were between 36 and 55 years of age (Mean 45.5 years SD: 11.1), had primary-level education (n=11, 68.8%), were self-employed (n=9, 56.3%), reported that they had self-repacked ART (n=14, 88%), and were taking ART for more than 6 years (n=11, 68.8%). Participants identified three attributes of ART packaging that increased anticipated HIV stigma and prompted self-repackaging, including visual identification, bulkiness, and the rattling noise produced by ART pill bottles.

conclusionGiven the drastic reduction in the number of pills required for HIV treatment, there is an opportunity to not only assess the cost-effectiveness of innovative ART packaging but also evaluate the acceptability of such packaging among PLWH in order to address stigma and improve ART adherence.

Indexed as

antiretroviral therapy packagingHIVqualitative researchself-packagingstigma

Identifiers

PMID32021125
PMCPMC6987964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.